openPR Logo
Press release

The non-hormonal therapies market is projected to be worth USD 10.9 billion in 2030, growing at an annualized rate of 21.7%, claims Roots Analysis

09-13-2021 10:10 AM CET | Health & Medicine

Press release from: Roots Analysis

The non-hormonal therapies market is projected to be worth USD

Driven by the potential to confer safe and sustained therapeutic effects for clinical conditions unique to women, the non-hormonal therapies pipeline is growing, featuring candidates having improved risk profiles and lesser side effects

Roots Analysis has announced the addition of “Non-hormonal Therapies for Women’s Health Market 2021 – 2030” report to its list of offerings.

In pursuit of an advantageous and risk-free prospect to hormonal therapies, the success of 21 approved non-hormonal therapies has resulted in a surge in the interest of drug developers in this rapidly evolving domain. As a result, the non-hormonal therapies market is abuzz with activity, in terms of partnerships and funding initiatives.

To order this 225+ page report, which features 92+ figures and 154+ tables, please visit https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market.html

Key Market Insights

Around 55 non-hormonal therapies are currently being developed across different stages
Apart from 21 approved products, close to 58% of the aforementioned candidates are being evaluated in clinical stages of development, with 2% of therapies in preclinical stages. It is worth mentioning that more than 80% of such drugs are small molecules. Further, majority of the therapies are being developed for the treatment of endometriosis (19%).

Over 64% of the non-hormonal therapy developers are based in North America
Interestingly, within the aforementioned region, majority of the players (21) are based in the US, which is considered a prominent R&D hub for advanced therapeutic products. Moreover, the current market is dominated by the presence of small players and very large firms, respectively.

220+ non-hormonal therapy focused clinical trials have been registered, worldwide
The clinical research activity, in terms of number of trials registered, is reported to have increased at a CAGR of 19% during the period 2015-2019. Of the total number of trials, close to 83% have already been completed, while 15% studies are presently active.

Partnership activity in this domain has grown at a CAGR of ~48%, between 2015 and 2020
Most of deals inked in the given time period were focused on development and commercialization (26%) of non-hormonal therapies. It is further important to note that, majority of the partnerships (7) related to such products were signed in 2020.

More than USD 800 million has been invested by various investors in this market, since 2016
So far, a significant proportion of the capital has been raised through private equity (USD 262.7 million). On the other hand, around USD 63.8 million was invested via venture capital rounds, representing 8% of the total amount.

North America and Europe are anticipated to capture over 94% of the total market share, in terms of sales revenues, in 2030
In addition, small molecules represent a significant share of the current market, and this trend is unlikely to change in the foreseen future. In terms of route of administration, therapies designed for delivery via the oral route are expected to capture the majority share of the market.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market/request-sample.html

Key Questions Answered
Who are the leading industry players engaged in the development of non-hormonal therapies?
How many non-hormonal therapy candidates are present in the current development pipeline? Which key women’s health related disease indications are targeted by such products?
Which commercialization strategies are most commonly adopted by non-hormonal therapy developers, across different stages of product development?
Which partnership models are commonly adopted by stakeholders engaged in this domain?
What are the key value drivers of the merger and acquisition activity in the non-hormonal therapies industry?
Who are the key stakeholders that have actively made investments in the non-hormonal therapy domain?
How is the current and future market opportunity likely to be distributed across key market segments?

The USD 10.5+ billion (by 2030) financial opportunity associated with non-hormonal therapies market has been analyzed across the following segments:

Target Indication
Bacterial vaginosis
Contraception
Endometriosis
Postmenopausal Osteoporosis
Uterine fibroids
Vaginitis
Others

Type of Molecule
Biologics
Small molecules

Route of Administration
Intramuscular
Intravaginal
Intravenous
Oral
Subcutaneous
Topical
Transdermal
Others

Key Geographical Regions
North America
Europe
Asia-Pacific

The research includes brief profiles of key players (listed below), engaged in the development of non-hormonal therapies; each profile features an overview of the therapy, current development status, clinical trials and their results (if available), target indication, route of administration and recent developments (if available). AbbVie
Astellas Pharma
Bayer
Daré Bioscience
Evofem Bioscience
Fougera Pharmaceuticals
Inmunotek
Mycovia Pharmaceuticals
Myovant Sciences
ObsEva
Radius Health
Scynexis

For additional details, please visit
https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market.html or email sales@rootsanalysis.com

You may also be interested in the following titles:
1. RNA Targeting Small Molecules Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030
2. Top Selling Biologics Market: Industry Trends and Global Forecasts, 2021-2030
3. Peptide Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The non-hormonal therapies market is projected to be worth USD 10.9 billion in 2030, growing at an annualized rate of 21.7%, claims Roots Analysis here

News-ID: 2390145 • Views:

More Releases from Roots Analysis

Proteomics Market CAGR To Be 7.9% % by 2035, Due To The Growing Adoption of Proteomics Solutions| Roots Analysis
Proteomics Market CAGR To Be 7.9% % by 2035, Due To The Growing Adoption of Prot …
According to our latest market report "Proteomics Market" by Type of Offering, Type of Instrument / Technology, Type of Reagent, Type of Proteomics Service, Application Area, End-users, Type of Operation and Geography: Industry Trends and Global Forecasts, Till 2035", the global protein expression market, valued at USD 2.7 billion in 2024, is estimated to reach USD 3.0 billion in 2025 and USD 6.3 billion by 2035, representing a CAGR of
Industrial Robotics Market to Reach USD 39.03 Billion by 2035, Driven by Rising Automation Demand Across Manufacturing | Roots Analysis
Industrial Robotics Market to Reach USD 39.03 Billion by 2035, Driven by Rising …
09-04-2025 | Robotics & Automation Press release from: Roots Analysis According to Roots Analysis' latest industry report titled "Industrial Robotics Market: Industry Trends and Global Forecasts, till 2035", the global industrial robotics market is projected to grow from USD 17.64 billion in 2024 to USD 18.80 billion in 2025, reaching USD 39.03 billion by 2035 at a CAGR of 7.5% during the forecast period. To request a quote for this report, visit: https://www.rootsanalysis.com/industrial-robotics-market/request-quote Market Overview Industrial
Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | Roots Analysis
Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | R …
According to our latest market report "Targeted Drug Delivery Device Market" by Type of Device, Target Organ, Type of Therapy Delivered, Route of Administration, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the targeted drug delivery device market size is projected to reach USD 2,153 million by 2035 from USD 427 million in 2026, growing at a CAGR of 19.7% in the forecast period, till
The Conjugation and Labeling Services Market is projected to grow at a CAGR of 10.3%, till 2035, claims Roots Analysis
The Conjugation and Labeling Services Market is projected to grow at a CAGR of 1 …
The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers To request quote of this report, please visit: https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market/request-quote.html Roots Analysis is pleased to announce the publication of its recent study, titled, "Conjugation and Labeling Services Market, 2023-2035" The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies.

All 5 Releases


More Releases for USD

Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and
Bamboo Clothing Market: USD 1.83B to USD 3.27B by 2030
Bamboo Clothing Market Poised for Robust Growth with Sustainability and Eco-Friendly Trends Driving Demand The global bamboo clothing market is experiencing substantial growth, spurred by a significant shift towards sustainable fashion and eco-friendly materials. As consumers become increasingly conscious of their environmental impact, bamboo fabric-known for its natural, biodegradable properties-is gaining popularity in the fashion industry. This market is expected to continue its upward trajectory, driven by rising demand for eco-conscious
Biometrics Market: "Biometrics: USD 34.3B to USD 112.4B by 2031"
Biometrics Market Market Scope: Key Insights : Biometrics Market size was valued at USD 34.3 billion in 2022 and is poised to grow from USD 39.1 billion in 2023 to USD 112.4 billion by 2031, growing at a CAGR of 14.1% during the forecast period (2024-2031). Discover Your Competitive Edge with a Free Sample Report :https://www.skyquestt.com/sample-request/biometrics-market Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/biometrics-market In-Depth Exploration of the global Biometrics
Advanced (3D/4D) Visualization Systems Market Size, Trends, Growth, Share to sur …
Fatpos Global has carefully studied specific areas, such as application and product type, in the global Advanced (3D/4D) Visualization Systems Market research study. During the predicted period of 2022 to 2032, each kind gives data on sales. The Advanced (3D/4D) Visualization Systems Market analysis examines into the characteristics and financials of the leading participants. As per the analysis research report, the Advanced (3D/4D) Visualization Systems Market to
$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com. There is a $3,000,000
IOT Solutions Market worth USD 553.9 million USD by 2026
"The global IoT solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cybersecurity as a service market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa." These days many businesses are adopting a market research report